MicroPort CardioFlow Medtech Corporation (2160.HK)

1.120 +0.070 (+6.67%) At close: 04:08PM HKT

MicroPort CardioFlow Medtech Corporation

No. 1661 Zhangdong Road
Zhangjiang Hi-Tech Park Pudong New District
Shanghai 201203
China
86 21 3895 4600
https://www.cardioflowmedtech.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 592

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jeffrey R Lindstrom	President, GM & Executive Director	N/A	N/A	1966
Ms. Luying Yan	VP & Executive Director	N/A	N/A	1982
Mr. Liang Zhao	Executive Director & First VP of Total Solutions	N/A	N/A	1979
Ms. Xiangmei Li	Joint Company Secretary	N/A	N/A	N/A
Ms. Lok Yee Chan A.C.I.S., A.C.S.	Joint Company Secretary	N/A	N/A	1990

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.

Corporate governance

MicroPort CardioFlow Medtech Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.